Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

PURPOSE OF REVIEW: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. RECENT FIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Aryal, Madan Raj, Gosain, Rohit, Donato, Anthony, Pathak, Ranjan, Bhatt, Vijaya Raj, Katel, Anjan, Kouides, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Hot Topic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288258/
https://www.ncbi.nlm.nih.gov/pubmed/32529517
http://dx.doi.org/10.1007/s11886-020-01327-9
Descripción
Sumario:PURPOSE OF REVIEW: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. RECENT FINDINGS: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. SUMMARY: Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.

Ejemplares similares